ranitidine has been researched along with Adrenal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doleschall, M; Farkas, H; Füst, G; Gláz, E; Igaz, P; Koncz, K; Korbonits, M; Patócs, A; Pázmándi, J; Prohászka, Z; Rácz, K; Szabó, JA; Szilágyi, Á; Tóth, M | 1 |
| Allo, M; Deutschman, CS; Nicholas, E; Rock, P | 1 |
2 other study(ies) available for ranitidine and Adrenal Cancer
| Article | Year |
|---|---|
Common genetic variants of the human steroid 21-hydroxylase gene (CYP21A2) are related to differences in circulating hormone levels.
Topics: 17-alpha-Hydroxyprogesterone; Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adult; Case-Control Studies; Female; Gene Frequency; Haplotypes; Heterozygote; Humans; Hydrocortisone; Linkage Disequilibrium; Male; Middle Aged; Polymorphism, Genetic; Ranitidine; Retrospective Studies; Steroid 21-Hydroxylase | 2014 |
Use of esmolol in the intraoperative management of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Diazepam; Female; Hemodynamics; Humans; Intraoperative Complications; Pheochromocytoma; Premedication; Propanolamines; Ranitidine | 1988 |